US Patent Issued to CHANGCHUN GENESCIENCE PHARMACEUTICAL on July 1 for "Anti-CD47 monoclonal antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,669, issued on July 1, was assigned to CHANGCHUN GENESCIENCE PHARMACEUTICAL Co. LTD. (Jilin, China).

"Anti-CD47 monoclonal antibody and use thereof" was invented by Xiao Feng (Jilin, China), Lei Jin (Jilin, China), Liang Xiao (Jilin, China), Tao Wang (Jilin, China) and Suofu Qin (Jilin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-CD47 monoclonal antibody and use thereof. The provided anti-CD47 monoclonal antibody can effectively inhibit tumor growth. Blocking human SIRP and human CD47 signals may enhance macrophage phagocytosis of tumor cells, prevent the tumor cells from escaping a tumor immune defense system, and have an anti-tumor...